206 related articles for article (PubMed ID: 9486668)
1. Expression of cyclin-dependent kinase inhibitors in vascular disease.
Tanner FC; Yang ZY; Duckers E; Gordon D; Nabel GJ; Nabel EG
Circ Res; 1998 Feb; 82(3):396-403. PubMed ID: 9486668
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
3. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity.
Ihling C; Technau K; Gross V; Schulte-Mönting J; Zeiher AM; Schaefer HE
Atherosclerosis; 1999 May; 144(1):7-14. PubMed ID: 10381272
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.
Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V
J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274
[TBL] [Abstract][Full Text] [Related]
5. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation.
Takagi Y
Hokkaido Igaku Zasshi; 2002 May; 77(3):221-30. PubMed ID: 12056049
[TBL] [Abstract][Full Text] [Related]
7. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
[TBL] [Abstract][Full Text] [Related]
8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
9. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
10. MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism.
Yu D; Makkar G; Dong T; Strickland DK; Sarkar R; Monahan TS
PLoS One; 2015; 10(11):e0141397. PubMed ID: 26528715
[TBL] [Abstract][Full Text] [Related]
11. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
Orend G; Hunter T; Ruoslahti E
Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1.
Bacqueville D; Casagrande F; Perret B; Chap H; Darbon JM; Breton-Douillon M
Biochem Biophys Res Commun; 1998 Mar; 244(3):630-6. PubMed ID: 9535716
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin-dependent kinase inhibitors, p21cip1 and p27kip1, during wound healing in rats.
Zhu X; Hu C; Zhang Y; Li L; Wang Z
Wound Repair Regen; 2001; 9(3):205-12. PubMed ID: 11472617
[TBL] [Abstract][Full Text] [Related]
16. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty.
Wei GL; Krasinski K; Kearney M; Isner JM; Walsh K; Andrés V
Circ Res; 1997 Mar; 80(3):418-26. PubMed ID: 9048663
[TBL] [Abstract][Full Text] [Related]
17. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
Morris TA; DeLorenzo RJ; Tombes RM
Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
[TBL] [Abstract][Full Text] [Related]
18. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors.
Koyama H; Raines EW; Bornfeldt KE; Roberts JM; Ross R
Cell; 1996 Dec; 87(6):1069-78. PubMed ID: 8978611
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.
Gallo R; Padurean A; Jayaraman T; Marx S; Roque M; Adelman S; Chesebro J; Fallon J; Fuster V; Marks A; Badimon JJ
Circulation; 1999 Apr; 99(16):2164-70. PubMed ID: 10217658
[TBL] [Abstract][Full Text] [Related]
20. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]